UBS Investment Bank

GLP-1s remain a focal point as US pricing reforms introduce new dynamics for investors. Will tighter margins slow growth - or open the door to new opportunities? Ash Verma, SMID Cap Biotech and Spec Pharma Analyst at UBS, shares his insights on how recent policy changes could impact the sector and how companies can adapt in our latest article in partnership with the Financial Times: https://from.ubs/6046sftXg Stay tuned for more insights post our UBS Global Healthcare Conference this November 9-12 in Palm Beach, Florida. #shareUBS #UBSconference

At UBS Japan Research, we’re deepening insight—because in a market defined by complexity, clarity is key. If you value the clarity we provide, please consider UBS in your Extel vote: https://from.ubs/6047sN7hH #shareUBS

On October 1, 2025, Veeco Instruments and Axcelis Technologies announced that they have entered into a definitive agreement to combine in an all-stock merger. This combination marks a transformational milestone for both Axcelis and Veeco. The combined company is expected to have an enterprise value of approximately $4.4 billion based on Axcelis' and Veeco's closing share prices as of September 30, 2025, and outstanding debt as of June 30, 2025. UBS is proud to have served as exclusive financial advisor to Veeco Instruments. #shareUBS

From cowboys to civil rights: Essential reads from the UBS Head of Americas Research Join Jim Van Tassel, Head of Americas Equity Research and Heidi Richardson, Head of EMEA Product Management from UBS Investment Bank, as they explore the power of literature and history in shaping perspectives, leadership decisions, and research insights. From historical epics to social commentary, hear about the books that inspire Jim. Listen on Spotify: https://from.ubs/6042s0T2o Listen on Apple: https://from.ubs/6043s0T2U #ShareUBS #UBSResearch

As our clients needs evolve, so does our approach to innovation. Daniel Dowd, Global Head of #UBSResearch, shares the latest on our AI avatar video initiative, reflecting our commitment to advancing the ways in which we deliver insightful and engaging content. #shareUBS

It was a true privilege to welcome renowned historian and author Niall Ferguson as a speaker at this year’s flagship conference, Best of Switzerland, held at Wolfsberg. In a world of rapid innovation, his message was clear: trust remains the foundation of resilient institutions. Watch the video and find out more. #shareUBS

#UBSResearch Japan analyst Kazefumi Takeuchi has a relatively optimistic outlook on the future of Japan hotels. Read on to learn why: https://from.ubs/6049sxrLU #shareUBS

Biotech is entering a new era of innovation. Noël Brown, Head of Biotech Banking, UBS, highlights how RNA editing and radioligand therapy are driving renewed confidence in the sector. With early clinical success and strategic acquisitions, the market is signaling it's ready for the next wave of innovation and investment. 🔗 Explore the full article in partnership with the Financial Times: https://from.ubs/6047sISl7 We will cover these topics and more at the UBS Global Healthcare Conference, November 9-12. Contact your UBS representative to learn more. #shareUBS #UBSconference

How do companies prepare for a successful IPO? Hear Gregor Feige, Co-Head of Americas ECM, UBS, and Mike DeSantis, Managing Director Insight Partners break down the steps, strategies and investor expectations that make the difference in a new episode of Crafting Capital with Custom Content from WSJ. Watch the full episode here: https://from.ubs/6046saYGs

Discover the latest insights shaping the exchange-traded and OTC-cleared derivatives marketplace in 2025. From developments in Asian markets to cross-asset trends in credit and commodities, and regulatory and policy shifts across EMIR 3 and the US, our latest quarterly update covers the key factors driving change. Visit our website for the latest insights or contact your UBS representative: https://from.ubs/6046sQf5Q #ShareUBS #ETD